The CEO & President of CDMO CordenPharma, Dr Michael Quirmbach, delves into the contract manufacturing industry, explaining the reasons behind the recent commercial success of his organization, including their partnership with Moderna, and his view on the new processes and technology shaping the industry.
A CDMO does not really innovate. We leave that task of research to our excellent customers. What we do well is stay on top of manufacturing processes and technology, and be efficient in our scale-up operations
